DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. of patients who received IVUS and 70.1%

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

DAIC

JANUARY 18, 2024

Photo: Business Wire milla1cf Thu, 01/18/2024 - 14:05 January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse Injectable balloon catheter platform.

Angioplasty 105

Angioplasty Peripheral Arterial Disease Kidney Disease Laboratory 105

DAIC

NOVEMBER 8, 2024

tim.hodson Fri, 11/08/2024 - 10:10 Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. Results from both analyses were released at the Vascular InterVentional Advances (VIVA) 2024 conference in Las Vegas. in observational studies and 67.9%

Stents 52

Stents Stent Angioplasty Peripheral Arterial Disease 52

DAIC

JANUARY 9, 2024

The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheral arterial and deep venous pathology." They also emphasized the need for further research and evidence to support the integration of IVUS into routine clinical practice.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4136687-A4136687, November 12, 2024. Background:Peripheral artery disease (PAD) is associated with high morbidity and mortality and is closely related to diabetes mellitus (DM) and atherosclerosis.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40